0

Lodoxamide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP53882125
CAS53882-12-5
Structure
MDL NumberMFCD00864803
Molecular Weight311.63
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to very dark brown
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Efficacy and Safety of 0.1% Lodoxamide for the Long-Term Treatment of Superior Limbic Keratoconjunctivitis

Alejandro Rodriguez-Garcia, Yolanda Macias-Rodriguez, Jose M Gonzalez-Gonzalez

Int Ophthalmol. 2018 Jun;38(3):1243-1249.

PMID: 28602013

1

GPR35 Mediates Lodoxamide-Induced Migration Inhibitory Response but Not CXCL17-induced Migration Stimulatory Response in THP-1 Cells; Is GPR35 a Receptor for CXCL17?

Soo-Jin Park, Seung-Jin Lee, So-Yeon Nam, Dong-Soon Im

Br J Pharmacol. 2018 Jan;175(1):154-161.

PMID: 29068046

1

Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35

Mi-Jeong Kim, Soo-Jin Park, So-Yeon Nam, Dong-Soon Im

Biomol Ther (Seoul). 2019 Jun 13;28(1):92-97.

PMID: 31189299

1

Protective Effect of Lodoxamide on Hepatic Steatosis Through GPR35

So-Yeon Nam, Soo-Jin Park, Dong-Soon Im

Cell Signal. 2019 Jan;53:190-200.

PMID: 30304698

1

Vernal Keratoconjunctivitis: A Severe Allergic Eye Disease With Remodeling Changes

Pakit Vichyanond, Punchama Pacharn, Uwe Pleyer, Andrea Leonardi

Pediatr Allergy Immunol. 2014 Jun;25(4):314-22.

PMID: 24438133

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode